1. Home
  2. EXEL vs SENEB Comparison

EXEL vs SENEB Comparison

Compare EXEL & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • SENEB
  • Stock Information
  • Founded
  • EXEL 1994
  • SENEB 1949
  • Country
  • EXEL United States
  • SENEB United States
  • Employees
  • EXEL N/A
  • SENEB N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • SENEB Packaged Foods
  • Sector
  • EXEL Health Care
  • SENEB Consumer Staples
  • Exchange
  • EXEL Nasdaq
  • SENEB Nasdaq
  • Market Cap
  • EXEL 9.8B
  • SENEB N/A
  • IPO Year
  • EXEL 2000
  • SENEB N/A
  • Fundamental
  • Price
  • EXEL $37.43
  • SENEB $86.92
  • Analyst Decision
  • EXEL Buy
  • SENEB
  • Analyst Count
  • EXEL 18
  • SENEB 0
  • Target Price
  • EXEL $37.59
  • SENEB N/A
  • AVG Volume (30 Days)
  • EXEL 2.4M
  • SENEB 242.0
  • Earning Date
  • EXEL 05-02-2025
  • SENEB 06-12-2025
  • Dividend Yield
  • EXEL N/A
  • SENEB N/A
  • EPS Growth
  • EXEL 170.77
  • SENEB 25.61
  • EPS
  • EXEL 1.76
  • SENEB 5.45
  • Revenue
  • EXEL $2,168,701,000.00
  • SENEB $1,541,031,000.00
  • Revenue This Year
  • EXEL $5.82
  • SENEB N/A
  • Revenue Next Year
  • EXEL $10.81
  • SENEB N/A
  • P/E Ratio
  • EXEL $21.27
  • SENEB $15.55
  • Revenue Growth
  • EXEL 18.50
  • SENEB 4.00
  • 52 Week Low
  • EXEL $20.14
  • SENEB $56.05
  • 52 Week High
  • EXEL $40.02
  • SENEB $90.99
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 57.87
  • SENEB 43.70
  • Support Level
  • EXEL $35.34
  • SENEB $85.79
  • Resistance Level
  • EXEL $37.67
  • SENEB $90.99
  • Average True Range (ATR)
  • EXEL 1.32
  • SENEB 0.00
  • MACD
  • EXEL 0.22
  • SENEB -0.62
  • Stochastic Oscillator
  • EXEL 95.46
  • SENEB 0.00

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About SENEB Seneca Foods Corp. Class B

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

Share on Social Networks: